Download presentation: Key issues in performing epidemiological vaccine safety studies

Key issues in performing epidemiological vaccine safety studies Dr Nick Andrews, Deputy Head, Statistics Modelling and Economics Department, Health Protection Agency joined us at the World Vaccine Congress Lyon to present on the key issues in performing epidemiological vaccine safety studies. An essential part of post licensure vaccine safety surveillance is signal testing using epi-studies. The use of routine data …

Exploring the potential of a microbial detection array

Founded in 1952 by Nobel Laureate E.O. Lawrence, the Lawrence Livermore National Laboratory is managed by the Department of Energy. With a large multi-disciplinary bioinformatics team, they focus on developing and delivering advanced detection assays. Dr Crystal Jaing, Group Leader, Applied Genomics, Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, joined us at the World Vaccine Congress in Washington in …

Developing a Scientifically Guided, Risk-Based Virus Safety Concept for a Cell-Derived Vaccine

How should we regulate the development and production of vaccines? Tell us below! Dr Jens-Peter Gregersen, Technology Development, Virus Safety and New Projects, Novartis Vaccines & Diagnostics joined us at the World Vaccine Congress earlier this year in Washington. To open, he began by asking: what is a scientifically guided, risk based concept? Scientifically guided Scientific data where possible and …

Current vaccine developments in the Chinese marketplace

Who better to fill us in on what the current vaccine development in the Chinese marketplace are than Dr Wang Hongguang, the Director-General for the China National Center for Biotechnology Development.   We will have the honour of welcoming Dr Wang at the 12th annual World Vaccine Congress in April, where he will be addressing the implications of the global …